Scientific Industries, Inc. (SCND) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
SCND representa a Scientific Industries, Inc., una empresa del sector Technology con un precio de $ (capitalización de mercado 0). La acción obtiene una puntuación de 52/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 15 mar 2026Perfil Tecnológico y Posición Competitiva de Scientific Industries, Inc. (SCND)
Scientific Industries, Inc. specializes in standard benchtop laboratory equipment, weight and measurement solutions, and bioprocessing systems, catering to research institutions and pharmaceutical companies. Operating in the scientific and technical instruments sector, the company distinguishes itself through its Genie and Torbal brands, offering a range of mixers, shakers, and scales.
Tesis de Inversión
Scientific Industries, Inc. presents a niche investment opportunity within the scientific and technical instruments sector. The company's diverse product range, including its Genie and Torbal brands, caters to a stable customer base in research and pharmaceutical industries. However, with a market capitalization of $0.01 billion and a negative profit margin of -11.7%, the company faces challenges in achieving profitability. A debt-to-equity ratio of 6.58 indicates a reliance on debt financing. Key catalysts for growth include expanding its bioprocessing systems offerings and increasing e-commerce sales. Potential risks include competition from larger players and the need for continuous innovation to maintain market relevance.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market Cap of $0.01 billion reflects its small size within the scientific instruments market.
- Gross Margin of 42.8% indicates a solid ability to control production costs, though this needs to translate to overall profitability.
- Negative Profit Margin of -11.7% highlights the need for improved operational efficiency and cost management.
- Debt-to-Equity Ratio of 6.58 suggests a high level of financial leverage, which could pose risks if revenue growth does not materialize.
- Beta of 0.38 indicates lower volatility compared to the broader market, potentially appealing to risk-averse investors.
Competidores y Pares
Fortalezas
- Established brands (Genie and Torbal).
- Specialized product offerings.
- Long-standing customer relationships.
- Proprietary technology in bioprocessing.
Debilidades
- Small market capitalization.
- Negative profit margin.
- High debt-to-equity ratio.
- Limited geographic presence.
Catalizadores
- Upcoming: Expansion of bioprocessing systems product line to meet growing demand in the biotechnology and pharmaceutical industries.
- Ongoing: Increasing e-commerce sales through enhanced online platform and digital marketing efforts.
- Ongoing: Strategic partnerships with universities and research institutions to drive innovation and product adoption.
- Upcoming: Geographic expansion into the Asia-Pacific region to capitalize on growth opportunities.
- Ongoing: Investment in research and development to introduce new and innovative products.
Riesgos
- Ongoing: Competition from larger players with greater resources and market share.
- Potential: Technological obsolescence due to rapid advancements in laboratory equipment and bioprocessing systems.
- Potential: Economic downturns affecting R&D spending by universities and pharmaceutical companies.
- Potential: Regulatory changes in the pharmaceutical industry impacting demand for certain products.
- Ongoing: High debt-to-equity ratio posing financial risks if revenue growth does not materialize.
Oportunidades de crecimiento
- Expansion of Bioprocessing Systems: Scientific Industries can capitalize on the growing demand for bioprocessing systems in the biotechnology and pharmaceutical industries. The global bioprocessing market is projected to reach $44.6 billion by 2027, offering a significant growth opportunity. By enhancing its product offerings and expanding its customer base in this segment, Scientific Industries can drive revenue growth and improve profitability.
- E-commerce Sales Growth: Increasing direct sales through e-commerce channels can improve profit margins and expand market reach. The global e-commerce market is expected to continue its upward trajectory, providing Scientific Industries with a cost-effective way to reach end-users directly. Investing in its online platform and digital marketing efforts can drive significant sales growth.
- Strategic Partnerships: Forming strategic partnerships with universities and research institutions can provide access to new technologies and markets. Collaborating on research projects and offering customized solutions can strengthen customer relationships and drive innovation. These partnerships can also lead to increased product adoption and revenue generation.
- Geographic Expansion: Expanding into new geographic markets, particularly in Asia-Pacific, can drive revenue growth. The Asia-Pacific region is experiencing rapid growth in the biotechnology and pharmaceutical industries, creating significant demand for laboratory equipment and bioprocessing systems. Establishing a presence in this region can diversify revenue streams and reduce reliance on existing markets.
- Product Innovation: Investing in research and development to introduce new and innovative products can maintain a competitive edge. Focusing on developing advanced bioprocessing systems and laboratory equipment can attract new customers and drive sales growth. Continuous innovation is crucial for staying ahead of competitors and meeting the evolving needs of the market.
Oportunidades
- Expansion of bioprocessing systems.
- Growth in e-commerce sales.
- Strategic partnerships with research institutions.
- Geographic expansion into Asia-Pacific.
Amenazas
- Competition from larger players.
- Technological obsolescence.
- Economic downturns affecting R&D spending.
- Regulatory changes in the pharmaceutical industry.
Ventajas competitivas
- Established brands (Genie and Torbal) with a reputation for quality.
- Specialized product offerings in niche segments.
- Long-standing relationships with key customers.
- Proprietary technology in bioprocessing systems.
Acerca de SCND
Scientific Industries, Inc., founded in 1954 and headquartered in Bohemia, New York, designs, manufactures, and markets a range of laboratory equipment, weight and measurement solutions, and bioprocessing systems. The company's products are utilized across various industries, including universities, pharmaceutical companies, national laboratories, and medical device manufacturers, for research purposes. Its product portfolio includes vortex mixers, various mixers and shakers under the Genie brand, which are designed to mix the contents of test tubes, beakers, and other containers. The company also offers multi-purpose rotators and rockers, as well as magnetic stirrers. Under the Torbal brand, Scientific Industries provides pharmacy, laboratory, and industrial digital scales, moisture analyzers, mechanical and automated pill counters, force gauges, and test stands products. Additionally, the company offers bioprocessing systems, including cell growth quantifiers, liquid injection systems, coaster systems, flow-through cells, multi-parameter sensors, and dissolved oxygen sensor pills. Scientific Industries sells its products through laboratory equipment distributors and directly to end-users via e-commerce, with operations spanning the United States, Germany, and other international markets.
Qué hacen
- Designs and manufactures standard benchtop laboratory equipment.
- Offers weight and measurement solutions under the Torbal brand.
- Provides bioprocessing systems for cell growth and monitoring.
- Sells vortex mixers and shakers under the Genie brand.
- Offers digital scales, moisture analyzers, and pill counters.
- Provides multi-parameter sensors and dissolved oxygen sensor pills.
- Markets products to universities, pharmaceutical companies, and research labs.
Modelo de Negocio
- Designs, manufactures, and sells laboratory equipment and bioprocessing systems.
- Generates revenue through direct sales to end-users and distributors.
- Offers a range of products under the Genie and Torbal brands.
- Focuses on serving the research and pharmaceutical industries.
Contexto de la Industria
Scientific Industries, Inc. operates in the scientific and technical instruments industry, a sector characterized by continuous innovation and demand from research institutions, pharmaceutical companies, and healthcare providers. The market is competitive, with larger players like Thermo Fisher Scientific and Danaher Corporation dominating. Scientific Industries focuses on niche segments with its benchtop laboratory equipment and bioprocessing systems. The industry is expected to grow, driven by increasing R&D spending and advancements in biotechnology and pharmaceuticals.
Clientes Clave
- Universities and research institutions
- Pharmaceutical companies
- National laboratories
- Medical device manufacturers
Finanzas
Gráfico e información
Precio de la acción de Scientific Industries, Inc. (SCND): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para SCND.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para SCND.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para SCND.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de SCND en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Clasificación
Industria Scientific & Technical InstrumentsCompetidores y Pares
Información del mercado OTC de SCND
The OTCQB Venture Market is the middle tier of the over-the-counter (OTC) market for U.S. companies. It is distinguished from the Pink market by requiring companies to be current in their reporting, undergo an annual verification process, and meet a minimum bid price test. While it offers more visibility than the Pink market, it does not have the stringent listing requirements of exchanges like the NYSE or NASDAQ, resulting in higher risk.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited Liquidity: OTC stocks generally have lower trading volumes, which can make it difficult to buy or sell shares quickly.
- Information Availability: While SCND maintains current disclosure, the level of scrutiny and information available may be less than that of exchange-listed companies.
- Price Volatility: OTC stocks can be more susceptible to price swings due to lower trading volumes and market capitalization.
- Regulatory Oversight: OTC markets have less regulatory oversight compared to major exchanges, increasing the risk of fraud or manipulation.
- Delisting Risk: Failure to meet OTCQB continued listing requirements could result in delisting and further reduced liquidity.
- Verify the company's financial statements and SEC filings.
- Research the management team and their track record.
- Assess the company's competitive position in its industry.
- Evaluate the company's growth prospects and potential catalysts.
- Understand the risks associated with investing in OTC stocks.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- Current Disclosure Status: Maintaining current reporting requirements on the OTCQB market.
- Established Business Operations: Scientific Industries has been in operation since 1954.
- Audited Financial Statements: Publicly available financial statements provide some level of transparency.
- OTCQB Listing: Being listed on the OTCQB market indicates a higher level of compliance compared to the Pink market.
- Positive Gross Margin: A gross margin of 42.8% suggests a viable business model.
Preguntas Comunes Sobre SCND
¿Cuáles son los factores clave para evaluar SCND?
Scientific Industries, Inc. (SCND) actualmente tiene una puntuación IA de 52/100, indicando puntuación moderada. Fortaleza clave: Established brands (Genie and Torbal).. Riesgo principal a monitorear: Ongoing: Competition from larger players with greater resources and market share.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de SCND?
SCND actualmente puntúa 52/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de SCND?
Los precios de SCND se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre SCND?
La cobertura de analistas para SCND incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en SCND?
Las categorías de riesgo para SCND incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Competition from larger players with greater resources and market share.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de SCND?
La relación P/E para SCND compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está SCND sobrevalorada o infravalorada?
Determinar si Scientific Industries, Inc. (SCND) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de SCND?
Scientific Industries, Inc. (SCND) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Financial data is based on the most recent available information.
- OTC analysis is based on general characteristics of the OTCQB market.
- Analyst opinions are limited due to the company's size and OTC listing.